nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—pancreatic cancer—stomach cancer	0.355	1	CtDrD
Sunitinib—PRKAA1—stomach cancer	0.0889	0.302	CbGaD
Sunitinib—FYN—stomach cancer	0.0889	0.302	CbGaD
Sunitinib—CHEK2—stomach cancer	0.0604	0.205	CbGaD
Sunitinib—FGFR2—stomach cancer	0.0563	0.191	CbGaD
Sunitinib—ABCC4—Fluorouracil—stomach cancer	0.0105	0.111	CbGbCtD
Sunitinib—ABCB1—Mitomycin—stomach cancer	0.0083	0.0874	CbGbCtD
Sunitinib—ABCC2—Irinotecan—stomach cancer	0.00653	0.0688	CbGbCtD
Sunitinib—ABCG2—Irinotecan—stomach cancer	0.00591	0.0622	CbGbCtD
Sunitinib—ABCC4—Methotrexate—stomach cancer	0.00581	0.0612	CbGbCtD
Sunitinib—ABCG2—Fluorouracil—stomach cancer	0.00567	0.0597	CbGbCtD
Sunitinib—ABCC2—Docetaxel—stomach cancer	0.00479	0.0504	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.00436	0.0459	CbGbCtD
Sunitinib—CYP3A7—Irinotecan—stomach cancer	0.00436	0.0459	CbGbCtD
Sunitinib—ABCG2—Docetaxel—stomach cancer	0.00433	0.0456	CbGbCtD
Sunitinib—ABCC2—Doxorubicin—stomach cancer	0.00357	0.0376	CbGbCtD
Sunitinib—ABCC2—Methotrexate—stomach cancer	0.00346	0.0364	CbGbCtD
Sunitinib—CYP3A5—Irinotecan—stomach cancer	0.00327	0.0345	CbGbCtD
Sunitinib—ABCG2—Doxorubicin—stomach cancer	0.00323	0.034	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0032	0.0337	CbGbCtD
Sunitinib—CYP3A7—Docetaxel—stomach cancer	0.0032	0.0337	CbGbCtD
Sunitinib—ABCG2—Methotrexate—stomach cancer	0.00313	0.0329	CbGbCtD
Sunitinib—CYP3A5—Docetaxel—stomach cancer	0.0024	0.0253	CbGbCtD
Sunitinib—ABCB1—Irinotecan—stomach cancer	0.00213	0.0224	CbGbCtD
Sunitinib—ABCB1—Docetaxel—stomach cancer	0.00156	0.0164	CbGbCtD
Sunitinib—CYP3A4—Irinotecan—stomach cancer	0.00128	0.0134	CbGbCtD
Sunitinib—ABCB1—Doxorubicin—stomach cancer	0.00116	0.0123	CbGbCtD
Sunitinib—ABCB1—Methotrexate—stomach cancer	0.00113	0.0119	CbGbCtD
Sunitinib—CYP3A4—Docetaxel—stomach cancer	0.000935	0.00985	CbGbCtD
Sunitinib—CYP3A4—Doxorubicin—stomach cancer	0.000697	0.00734	CbGbCtD
Sunitinib—Procainamide—DNMT1—stomach cancer	0.000592	1	CrCbGaD
Sunitinib—DYRK1A—Topotecan—Irinotecan—stomach cancer	0.000328	0.195	CbGdCrCtD
Sunitinib—PLK4—Topotecan—Irinotecan—stomach cancer	0.000224	0.133	CbGdCrCtD
Sunitinib—CHEK2—Paclitaxel—Docetaxel—stomach cancer	0.000138	0.0823	CbGdCrCtD
Sunitinib—SNRK—lymph node—stomach cancer	7.74e-05	0.00117	CbGeAlD
Sunitinib—OXSR1—lymph node—stomach cancer	7.74e-05	0.00117	CbGeAlD
Sunitinib—CSNK1A1—endocrine gland—stomach cancer	7.72e-05	0.00117	CbGeAlD
Sunitinib—DYRK1A—Idarubicin—Epirubicin—stomach cancer	7.7e-05	0.0458	CbGdCrCtD
Sunitinib—DYRK1A—Daunorubicin—Epirubicin—stomach cancer	7.7e-05	0.0458	CbGdCrCtD
Sunitinib—DYRK1A—Doxorubicin—Epirubicin—stomach cancer	7.7e-05	0.0458	CbGdCrCtD
Sunitinib—ULK3—bone marrow—stomach cancer	7.69e-05	0.00117	CbGeAlD
Sunitinib—MAP2K2—bone marrow—stomach cancer	7.69e-05	0.00117	CbGeAlD
Sunitinib—CLK1—endocrine gland—stomach cancer	7.67e-05	0.00116	CbGeAlD
Sunitinib—YES1—pancreas—stomach cancer	7.64e-05	0.00116	CbGeAlD
Sunitinib—MAP3K2—bone marrow—stomach cancer	7.63e-05	0.00116	CbGeAlD
Sunitinib—DYRK1A—liver—stomach cancer	7.62e-05	0.00116	CbGeAlD
Sunitinib—RPS6KA2—lymph node—stomach cancer	7.62e-05	0.00115	CbGeAlD
Sunitinib—STK38—lymph node—stomach cancer	7.62e-05	0.00115	CbGeAlD
Sunitinib—KDR—epithelium—stomach cancer	7.59e-05	0.00115	CbGeAlD
Sunitinib—MAP3K7—bone marrow—stomach cancer	7.56e-05	0.00115	CbGeAlD
Sunitinib—AURKC—lymph node—stomach cancer	7.56e-05	0.00115	CbGeAlD
Sunitinib—TAOK3—pancreas—stomach cancer	7.54e-05	0.00114	CbGeAlD
Sunitinib—BMP2K—endocrine gland—stomach cancer	7.53e-05	0.00114	CbGeAlD
Sunitinib—CAMK2G—endocrine gland—stomach cancer	7.53e-05	0.00114	CbGeAlD
Sunitinib—CSNK1G2—lymph node—stomach cancer	7.5e-05	0.00114	CbGeAlD
Sunitinib—PKN1—lymph node—stomach cancer	7.5e-05	0.00114	CbGeAlD
Sunitinib—TBK1—bone marrow—stomach cancer	7.47e-05	0.00113	CbGeAlD
Sunitinib—LRRK2—endocrine gland—stomach cancer	7.47e-05	0.00113	CbGeAlD
Sunitinib—MERTK—liver—stomach cancer	7.44e-05	0.00113	CbGeAlD
Sunitinib—TYK2—bone marrow—stomach cancer	7.42e-05	0.00113	CbGeAlD
Sunitinib—JAK2—lymphoid tissue—stomach cancer	7.42e-05	0.00112	CbGeAlD
Sunitinib—PRPF4—lymph node—stomach cancer	7.39e-05	0.00112	CbGeAlD
Sunitinib—FGFR2—digestive system—stomach cancer	7.37e-05	0.00112	CbGeAlD
Sunitinib—PRKAA1—endocrine gland—stomach cancer	7.36e-05	0.00112	CbGeAlD
Sunitinib—KIT—hematopoietic system—stomach cancer	7.35e-05	0.00112	CbGeAlD
Sunitinib—IRAK1—bone marrow—stomach cancer	7.33e-05	0.00111	CbGeAlD
Sunitinib—JAK2—digestive system—stomach cancer	7.33e-05	0.00111	CbGeAlD
Sunitinib—FYN—lymphoid tissue—stomach cancer	7.32e-05	0.00111	CbGeAlD
Sunitinib—KDR—smooth muscle tissue—stomach cancer	7.31e-05	0.00111	CbGeAlD
Sunitinib—MAP4K4—liver—stomach cancer	7.31e-05	0.00111	CbGeAlD
Sunitinib—PRPF4B—lymph node—stomach cancer	7.29e-05	0.0011	CbGeAlD
Sunitinib—PTK2B—endocrine gland—stomach cancer	7.28e-05	0.0011	CbGeAlD
Sunitinib—FLT4—endocrine gland—stomach cancer	7.26e-05	0.0011	CbGeAlD
Sunitinib—NUAK2—liver—stomach cancer	7.25e-05	0.0011	CbGeAlD
Sunitinib—FYN—digestive system—stomach cancer	7.23e-05	0.0011	CbGeAlD
Sunitinib—FLT3—liver—stomach cancer	7.2e-05	0.00109	CbGeAlD
Sunitinib—MAP3K12—liver—stomach cancer	7.2e-05	0.00109	CbGeAlD
Sunitinib—RPS6KB1—bone marrow—stomach cancer	7.19e-05	0.00109	CbGeAlD
Sunitinib—STK39—lymph node—stomach cancer	7.19e-05	0.00109	CbGeAlD
Sunitinib—PDGFRB—hematopoietic system—stomach cancer	7.18e-05	0.00109	CbGeAlD
Sunitinib—CSNK1E—endocrine gland—stomach cancer	7.16e-05	0.00109	CbGeAlD
Sunitinib—MAP4K5—lymphoid tissue—stomach cancer	7.15e-05	0.00108	CbGeAlD
Sunitinib—FGR—bone marrow—stomach cancer	7.15e-05	0.00108	CbGeAlD
Sunitinib—CSF1R—smooth muscle tissue—stomach cancer	7.13e-05	0.00108	CbGeAlD
Sunitinib—DYRK1A—Daunorubicin—Doxorubicin—stomach cancer	7.13e-05	0.0423	CbGdCrCtD
Sunitinib—DYRK1A—Idarubicin—Doxorubicin—stomach cancer	7.13e-05	0.0423	CbGdCrCtD
Sunitinib—DYRK1A—Epirubicin—Doxorubicin—stomach cancer	7.13e-05	0.0423	CbGdCrCtD
Sunitinib—RPS6KA3—liver—stomach cancer	7.1e-05	0.00108	CbGeAlD
Sunitinib—CSNK2A1—lymph node—stomach cancer	7.09e-05	0.00108	CbGeAlD
Sunitinib—MAP2K1—liver—stomach cancer	7.06e-05	0.00107	CbGeAlD
Sunitinib—MYLK—lymph node—stomach cancer	7e-05	0.00106	CbGeAlD
Sunitinib—CSNK1A1—liver—stomach cancer	6.96e-05	0.00106	CbGeAlD
Sunitinib—CLK1—liver—stomach cancer	6.92e-05	0.00105	CbGeAlD
Sunitinib—PLK4—lymph node—stomach cancer	6.91e-05	0.00105	CbGeAlD
Sunitinib—FLT1—lymphoid tissue—stomach cancer	6.91e-05	0.00105	CbGeAlD
Sunitinib—MAP2K2—endocrine gland—stomach cancer	6.89e-05	0.00104	CbGeAlD
Sunitinib—ULK3—endocrine gland—stomach cancer	6.89e-05	0.00104	CbGeAlD
Sunitinib—STK4—lymph node—stomach cancer	6.87e-05	0.00104	CbGeAlD
Sunitinib—SLK—bone marrow—stomach cancer	6.85e-05	0.00104	CbGeAlD
Sunitinib—MAP3K2—endocrine gland—stomach cancer	6.84e-05	0.00104	CbGeAlD
Sunitinib—FLT1—digestive system—stomach cancer	6.83e-05	0.00104	CbGeAlD
Sunitinib—CAMK2G—liver—stomach cancer	6.79e-05	0.00103	CbGeAlD
Sunitinib—BMP2K—liver—stomach cancer	6.79e-05	0.00103	CbGeAlD
Sunitinib—JAK2—bone marrow—stomach cancer	6.75e-05	0.00102	CbGeAlD
Sunitinib—PHKG2—lymph node—stomach cancer	6.75e-05	0.00102	CbGeAlD
Sunitinib—LRRK2—liver—stomach cancer	6.73e-05	0.00102	CbGeAlD
Sunitinib—KIT—epithelium—stomach cancer	6.72e-05	0.00102	CbGeAlD
Sunitinib—STK24—lymph node—stomach cancer	6.71e-05	0.00102	CbGeAlD
Sunitinib—TBK1—endocrine gland—stomach cancer	6.7e-05	0.00102	CbGeAlD
Sunitinib—FYN—bone marrow—stomach cancer	6.66e-05	0.00101	CbGeAlD
Sunitinib—TYK2—endocrine gland—stomach cancer	6.65e-05	0.00101	CbGeAlD
Sunitinib—PRPF4—Idarubicin—Epirubicin—stomach cancer	6.65e-05	0.0395	CbGdCrCtD
Sunitinib—PRPF4—Daunorubicin—Epirubicin—stomach cancer	6.65e-05	0.0395	CbGdCrCtD
Sunitinib—DAPK2—lymph node—stomach cancer	6.64e-05	0.00101	CbGeAlD
Sunitinib—PRKAA1—liver—stomach cancer	6.63e-05	0.00101	CbGeAlD
Sunitinib—YES1—lymphoid tissue—stomach cancer	6.6e-05	0.001	CbGeAlD
Sunitinib—PDGFRB—epithelium—stomach cancer	6.57e-05	0.000995	CbGeAlD
Sunitinib—PTK2B—liver—stomach cancer	6.56e-05	0.000995	CbGeAlD
Sunitinib—STK10—lymphoid tissue—stomach cancer	6.54e-05	0.000992	CbGeAlD
Sunitinib—FLT4—liver—stomach cancer	6.54e-05	0.000992	CbGeAlD
Sunitinib—STK16—lymph node—stomach cancer	6.53e-05	0.00099	CbGeAlD
Sunitinib—YES1—digestive system—stomach cancer	6.52e-05	0.000989	CbGeAlD
Sunitinib—TAOK3—lymphoid tissue—stomach cancer	6.52e-05	0.000988	CbGeAlD
Sunitinib—MAP4K5—bone marrow—stomach cancer	6.51e-05	0.000987	CbGeAlD
Sunitinib—MAP3K3—bone marrow—stomach cancer	6.51e-05	0.000987	CbGeAlD
Sunitinib—HIPK2—lymph node—stomach cancer	6.49e-05	0.000985	CbGeAlD
Sunitinib—HIPK3—lymph node—stomach cancer	6.49e-05	0.000985	CbGeAlD
Sunitinib—ALK—lymph node—stomach cancer	6.49e-05	0.000985	CbGeAlD
Sunitinib—KIT—smooth muscle tissue—stomach cancer	6.48e-05	0.000982	CbGeAlD
Sunitinib—PDGFRA—lymphoid tissue—stomach cancer	6.48e-05	0.000982	CbGeAlD
Sunitinib—STK10—digestive system—stomach cancer	6.46e-05	0.00098	CbGeAlD
Sunitinib—CSNK1E—liver—stomach cancer	6.45e-05	0.000978	CbGeAlD
Sunitinib—FGFR1—liver—stomach cancer	6.45e-05	0.000978	CbGeAlD
Sunitinib—RPS6KB1—endocrine gland—stomach cancer	6.44e-05	0.000977	CbGeAlD
Sunitinib—TAOK3—digestive system—stomach cancer	6.44e-05	0.000976	CbGeAlD
Sunitinib—RIOK2—lymph node—stomach cancer	6.43e-05	0.000974	CbGeAlD
Sunitinib—TNK1—lymph node—stomach cancer	6.43e-05	0.000974	CbGeAlD
Sunitinib—FGR—endocrine gland—stomach cancer	6.41e-05	0.000971	CbGeAlD
Sunitinib—RET—endocrine gland—stomach cancer	6.41e-05	0.000971	CbGeAlD
Sunitinib—PDGFRA—digestive system—stomach cancer	6.4e-05	0.00097	CbGeAlD
Sunitinib—AXL—endocrine gland—stomach cancer	6.38e-05	0.000967	CbGeAlD
Sunitinib—MAP4K1—lymph node—stomach cancer	6.36e-05	0.000965	CbGeAlD
Sunitinib—IRAK4—liver—stomach cancer	6.35e-05	0.000963	CbGeAlD
Sunitinib—PDGFRB—smooth muscle tissue—stomach cancer	6.33e-05	0.000959	CbGeAlD
Sunitinib—DAPK3—lymph node—stomach cancer	6.24e-05	0.000946	CbGeAlD
Sunitinib—MAP2K2—liver—stomach cancer	6.21e-05	0.000942	CbGeAlD
Sunitinib—ULK3—liver—stomach cancer	6.21e-05	0.000942	CbGeAlD
Sunitinib—CLK2—lymph node—stomach cancer	6.18e-05	0.000937	CbGeAlD
Sunitinib—MAP3K2—liver—stomach cancer	6.17e-05	0.000935	CbGeAlD
Sunitinib—MAP4K2—lymph node—stomach cancer	6.15e-05	0.000933	CbGeAlD
Sunitinib—PRPF4—Daunorubicin—Doxorubicin—stomach cancer	6.15e-05	0.0366	CbGdCrCtD
Sunitinib—PRPF4—Idarubicin—Doxorubicin—stomach cancer	6.15e-05	0.0366	CbGdCrCtD
Sunitinib—CYP3A7—endocrine gland—stomach cancer	6.12e-05	0.000928	CbGeAlD
Sunitinib—MAP3K7—liver—stomach cancer	6.11e-05	0.000926	CbGeAlD
Sunitinib—FGFR2—endocrine gland—stomach cancer	6.09e-05	0.000923	CbGeAlD
Sunitinib—STK3—lymph node—stomach cancer	6.07e-05	0.00092	CbGeAlD
Sunitinib—JAK2—endocrine gland—stomach cancer	6.05e-05	0.000918	CbGeAlD
Sunitinib—TBK1—liver—stomach cancer	6.04e-05	0.000916	CbGeAlD
Sunitinib—YES1—bone marrow—stomach cancer	6.01e-05	0.000911	CbGeAlD
Sunitinib—TYK2—liver—stomach cancer	6e-05	0.00091	CbGeAlD
Sunitinib—KIT—pancreas—stomach cancer	5.99e-05	0.000908	CbGeAlD
Sunitinib—FYN—endocrine gland—stomach cancer	5.97e-05	0.000905	CbGeAlD
Sunitinib—STK10—bone marrow—stomach cancer	5.96e-05	0.000903	CbGeAlD
Sunitinib—TAOK3—bone marrow—stomach cancer	5.93e-05	0.0009	CbGeAlD
Sunitinib—IRAK1—liver—stomach cancer	5.92e-05	0.000898	CbGeAlD
Sunitinib—PDGFRB—pancreas—stomach cancer	5.85e-05	0.000887	CbGeAlD
Sunitinib—KDR—lymphoid tissue—stomach cancer	5.84e-05	0.000886	CbGeAlD
Sunitinib—DYRK1A—lymph node—stomach cancer	5.84e-05	0.000886	CbGeAlD
Sunitinib—MAP4K5—endocrine gland—stomach cancer	5.83e-05	0.000885	CbGeAlD
Sunitinib—MAP3K3—endocrine gland—stomach cancer	5.83e-05	0.000885	CbGeAlD
Sunitinib—RPS6KB1—liver—stomach cancer	5.81e-05	0.000881	CbGeAlD
Sunitinib—FGR—liver—stomach cancer	5.78e-05	0.000876	CbGeAlD
Sunitinib—KDR—digestive system—stomach cancer	5.77e-05	0.000875	CbGeAlD
Sunitinib—AXL—liver—stomach cancer	5.75e-05	0.000872	CbGeAlD
Sunitinib—ABCC4—hematopoietic system—stomach cancer	5.72e-05	0.000867	CbGeAlD
Sunitinib—MERTK—lymph node—stomach cancer	5.71e-05	0.000865	CbGeAlD
Sunitinib—CSF1R—lymphoid tissue—stomach cancer	5.7e-05	0.000865	CbGeAlD
Sunitinib—FLT1—endocrine gland—stomach cancer	5.64e-05	0.000855	CbGeAlD
Sunitinib—CSF1R—digestive system—stomach cancer	5.63e-05	0.000854	CbGeAlD
Sunitinib—MAP4K4—lymph node—stomach cancer	5.6e-05	0.000849	CbGeAlD
Sunitinib—NUAK2—lymph node—stomach cancer	5.56e-05	0.000843	CbGeAlD
Sunitinib—SLK—liver—stomach cancer	5.54e-05	0.000839	CbGeAlD
Sunitinib—MAP3K12—lymph node—stomach cancer	5.52e-05	0.000837	CbGeAlD
Sunitinib—FLT3—lymph node—stomach cancer	5.52e-05	0.000837	CbGeAlD
Sunitinib—CYP3A7—liver—stomach cancer	5.52e-05	0.000836	CbGeAlD
Sunitinib—FGFR2—liver—stomach cancer	5.49e-05	0.000832	CbGeAlD
Sunitinib—JAK2—liver—stomach cancer	5.46e-05	0.000828	CbGeAlD
Sunitinib—RPS6KA3—lymph node—stomach cancer	5.45e-05	0.000826	CbGeAlD
Sunitinib—MAP2K1—lymph node—stomach cancer	5.41e-05	0.00082	CbGeAlD
Sunitinib—YES1—endocrine gland—stomach cancer	5.39e-05	0.000817	CbGeAlD
Sunitinib—FYN—liver—stomach cancer	5.38e-05	0.000816	CbGeAlD
Sunitinib—STK10—endocrine gland—stomach cancer	5.34e-05	0.00081	CbGeAlD
Sunitinib—CSNK1A1—lymph node—stomach cancer	5.34e-05	0.00081	CbGeAlD
Sunitinib—KDR—bone marrow—stomach cancer	5.32e-05	0.000807	CbGeAlD
Sunitinib—TAOK3—endocrine gland—stomach cancer	5.32e-05	0.000807	CbGeAlD
Sunitinib—CLK1—lymph node—stomach cancer	5.31e-05	0.000804	CbGeAlD
Sunitinib—PDGFRA—endocrine gland—stomach cancer	5.29e-05	0.000801	CbGeAlD
Sunitinib—PLK4—Idarubicin—Epirubicin—stomach cancer	5.26e-05	0.0313	CbGdCrCtD
Sunitinib—PLK4—Doxorubicin—Epirubicin—stomach cancer	5.26e-05	0.0313	CbGdCrCtD
Sunitinib—MAP4K5—liver—stomach cancer	5.26e-05	0.000798	CbGeAlD
Sunitinib—MAP3K3—liver—stomach cancer	5.26e-05	0.000798	CbGeAlD
Sunitinib—CAMK2G—lymph node—stomach cancer	5.21e-05	0.00079	CbGeAlD
Sunitinib—BMP2K—lymph node—stomach cancer	5.21e-05	0.00079	CbGeAlD
Sunitinib—CSF1R—bone marrow—stomach cancer	5.19e-05	0.000787	CbGeAlD
Sunitinib—KIT—lymphoid tissue—stomach cancer	5.18e-05	0.000785	CbGeAlD
Sunitinib—LRRK2—lymph node—stomach cancer	5.16e-05	0.000782	CbGeAlD
Sunitinib—KIT—digestive system—stomach cancer	5.11e-05	0.000775	CbGeAlD
Sunitinib—PRKAA1—lymph node—stomach cancer	5.09e-05	0.000771	CbGeAlD
Sunitinib—FLT1—liver—stomach cancer	5.09e-05	0.000771	CbGeAlD
Sunitinib—PDGFRB—lymphoid tissue—stomach cancer	5.06e-05	0.000767	CbGeAlD
Sunitinib—PTK2B—lymph node—stomach cancer	5.03e-05	0.000763	CbGeAlD
Sunitinib—FLT4—lymph node—stomach cancer	5.02e-05	0.00076	CbGeAlD
Sunitinib—PDGFRB—digestive system—stomach cancer	5e-05	0.000757	CbGeAlD
Sunitinib—CSNK1E—lymph node—stomach cancer	4.95e-05	0.00075	CbGeAlD
Sunitinib—FGFR1—lymph node—stomach cancer	4.95e-05	0.00075	CbGeAlD
Sunitinib—IRAK4—lymph node—stomach cancer	4.87e-05	0.000739	CbGeAlD
Sunitinib—PLK4—Idarubicin—Doxorubicin—stomach cancer	4.87e-05	0.0289	CbGdCrCtD
Sunitinib—PLK4—Epirubicin—Doxorubicin—stomach cancer	4.87e-05	0.0289	CbGdCrCtD
Sunitinib—YES1—liver—stomach cancer	4.86e-05	0.000737	CbGeAlD
Sunitinib—STK10—liver—stomach cancer	4.81e-05	0.00073	CbGeAlD
Sunitinib—TAOK3—liver—stomach cancer	4.8e-05	0.000727	CbGeAlD
Sunitinib—KDR—endocrine gland—stomach cancer	4.77e-05	0.000723	CbGeAlD
Sunitinib—MAP2K5—endocrine gland—stomach cancer	4.77e-05	0.000723	CbGeAlD
Sunitinib—PDGFRA—liver—stomach cancer	4.77e-05	0.000723	CbGeAlD
Sunitinib—ULK3—lymph node—stomach cancer	4.76e-05	0.000722	CbGeAlD
Sunitinib—MAP2K2—lymph node—stomach cancer	4.76e-05	0.000722	CbGeAlD
Sunitinib—MAP3K2—lymph node—stomach cancer	4.73e-05	0.000717	CbGeAlD
Sunitinib—KIT—bone marrow—stomach cancer	4.71e-05	0.000715	CbGeAlD
Sunitinib—CYP3A7-CYP3A51P—liver—stomach cancer	4.69e-05	0.000711	CbGeAlD
Sunitinib—MAP3K7—lymph node—stomach cancer	4.68e-05	0.00071	CbGeAlD
Sunitinib—ABCC4—pancreas—stomach cancer	4.66e-05	0.000706	CbGeAlD
Sunitinib—CSF1R—endocrine gland—stomach cancer	4.65e-05	0.000706	CbGeAlD
Sunitinib—CHEK2—Doxorubicin—Epirubicin—stomach cancer	4.64e-05	0.0276	CbGdCrCtD
Sunitinib—TBK1—lymph node—stomach cancer	4.63e-05	0.000702	CbGeAlD
Sunitinib—PDGFRB—bone marrow—stomach cancer	4.6e-05	0.000698	CbGeAlD
Sunitinib—TYK2—lymph node—stomach cancer	4.6e-05	0.000697	CbGeAlD
Sunitinib—IRAK1—lymph node—stomach cancer	4.54e-05	0.000688	CbGeAlD
Sunitinib—KCNH2—hematopoietic system—stomach cancer	4.54e-05	0.000688	CbGeAlD
Sunitinib—RPS6KB1—lymph node—stomach cancer	4.45e-05	0.000675	CbGeAlD
Sunitinib—FGR—lymph node—stomach cancer	4.43e-05	0.000671	CbGeAlD
Sunitinib—RET—lymph node—stomach cancer	4.43e-05	0.000671	CbGeAlD
Sunitinib—AXL—lymph node—stomach cancer	4.41e-05	0.000669	CbGeAlD
Sunitinib—KDR—liver—stomach cancer	4.3e-05	0.000652	CbGeAlD
Sunitinib—MAP2K5—liver—stomach cancer	4.3e-05	0.000652	CbGeAlD
Sunitinib—CHEK2—Epirubicin—Doxorubicin—stomach cancer	4.29e-05	0.0255	CbGdCrCtD
Sunitinib—SLK—lymph node—stomach cancer	4.25e-05	0.000644	CbGeAlD
Sunitinib—KIT—endocrine gland—stomach cancer	4.23e-05	0.000641	CbGeAlD
Sunitinib—CSF1R—liver—stomach cancer	4.2e-05	0.000636	CbGeAlD
Sunitinib—JAK2—lymph node—stomach cancer	4.18e-05	0.000634	CbGeAlD
Sunitinib—PDGFRB—endocrine gland—stomach cancer	4.13e-05	0.000626	CbGeAlD
Sunitinib—FYN—lymph node—stomach cancer	4.13e-05	0.000626	CbGeAlD
Sunitinib—MAP4K5—lymph node—stomach cancer	4.03e-05	0.000612	CbGeAlD
Sunitinib—MAP3K3—lymph node—stomach cancer	4.03e-05	0.000612	CbGeAlD
Sunitinib—ABCC4—digestive system—stomach cancer	3.98e-05	0.000603	CbGeAlD
Sunitinib—FLT1—lymph node—stomach cancer	3.9e-05	0.000591	CbGeAlD
Sunitinib—EPHB6—lymph node—stomach cancer	3.85e-05	0.000584	CbGeAlD
Sunitinib—ABCC2—digestive system—stomach cancer	3.85e-05	0.000584	CbGeAlD
Sunitinib—KIT—liver—stomach cancer	3.81e-05	0.000578	CbGeAlD
Sunitinib—CYP3A5—hematopoietic system—stomach cancer	3.75e-05	0.000568	CbGeAlD
Sunitinib—ABCB1—blood vessel—stomach cancer	3.74e-05	0.000567	CbGeAlD
Sunitinib—YES1—lymph node—stomach cancer	3.73e-05	0.000565	CbGeAlD
Sunitinib—PDGFRB—liver—stomach cancer	3.72e-05	0.000564	CbGeAlD
Sunitinib—STK10—lymph node—stomach cancer	3.69e-05	0.00056	CbGeAlD
Sunitinib—TAOK3—lymph node—stomach cancer	3.68e-05	0.000558	CbGeAlD
Sunitinib—ABCC4—bone marrow—stomach cancer	3.67e-05	0.000556	CbGeAlD
Sunitinib—PDGFRA—lymph node—stomach cancer	3.65e-05	0.000554	CbGeAlD
Sunitinib—KDR—lymph node—stomach cancer	3.3e-05	0.0005	CbGeAlD
Sunitinib—MAP2K5—lymph node—stomach cancer	3.3e-05	0.0005	CbGeAlD
Sunitinib—ABCC4—endocrine gland—stomach cancer	3.29e-05	0.000498	CbGeAlD
Sunitinib—CSF1R—lymph node—stomach cancer	3.22e-05	0.000488	CbGeAlD
Sunitinib—ABCC2—endocrine gland—stomach cancer	3.18e-05	0.000482	CbGeAlD
Sunitinib—CYP3A5—pancreas—stomach cancer	3.05e-05	0.000463	CbGeAlD
Sunitinib—ABCC4—liver—stomach cancer	2.96e-05	0.000449	CbGeAlD
Sunitinib—KIT—lymph node—stomach cancer	2.92e-05	0.000443	CbGeAlD
Sunitinib—KCNH2—bone marrow—stomach cancer	2.91e-05	0.000441	CbGeAlD
Sunitinib—ABCC2—liver—stomach cancer	2.87e-05	0.000435	CbGeAlD
Sunitinib—PDGFRB—lymph node—stomach cancer	2.85e-05	0.000433	CbGeAlD
Sunitinib—CYP3A4—hematopoietic system—stomach cancer	2.81e-05	0.000426	CbGeAlD
Sunitinib—KCNH2—endocrine gland—stomach cancer	2.61e-05	0.000395	CbGeAlD
Sunitinib—CYP3A5—digestive system—stomach cancer	2.61e-05	0.000395	CbGeAlD
Sunitinib—ABCG2—bone marrow—stomach cancer	2.59e-05	0.000392	CbGeAlD
Sunitinib—Infection—Capecitabine—stomach cancer	2.53e-05	0.000318	CcSEcCtD
Sunitinib—Erythema multiforme—Methotrexate—stomach cancer	2.52e-05	0.000317	CcSEcCtD
Sunitinib—Neuropathy peripheral—Doxorubicin—stomach cancer	2.52e-05	0.000317	CcSEcCtD
Sunitinib—Dizziness—Irinotecan—stomach cancer	2.52e-05	0.000316	CcSEcCtD
Sunitinib—Haemoglobin—Epirubicin—stomach cancer	2.51e-05	0.000315	CcSEcCtD
Sunitinib—Stomatitis—Doxorubicin—stomach cancer	2.51e-05	0.000315	CcSEcCtD
Sunitinib—Anorexia—Docetaxel—stomach cancer	2.51e-05	0.000315	CcSEcCtD
Sunitinib—Shock—Capecitabine—stomach cancer	2.51e-05	0.000314	CcSEcCtD
Sunitinib—Urinary tract infection—Doxorubicin—stomach cancer	2.5e-05	0.000314	CcSEcCtD
Sunitinib—Nervous system disorder—Capecitabine—stomach cancer	2.5e-05	0.000313	CcSEcCtD
Sunitinib—Haemorrhage—Epirubicin—stomach cancer	2.5e-05	0.000313	CcSEcCtD
Sunitinib—Hepatitis—Epirubicin—stomach cancer	2.5e-05	0.000313	CcSEcCtD
Sunitinib—Eye disorder—Methotrexate—stomach cancer	2.5e-05	0.000313	CcSEcCtD
Sunitinib—Diarrhoea—Fluorouracil—stomach cancer	2.49e-05	0.000313	CcSEcCtD
Sunitinib—Thrombocytopenia—Capecitabine—stomach cancer	2.49e-05	0.000313	CcSEcCtD
Sunitinib—Hypoaesthesia—Epirubicin—stomach cancer	2.49e-05	0.000312	CcSEcCtD
Sunitinib—Cardiac disorder—Methotrexate—stomach cancer	2.48e-05	0.000311	CcSEcCtD
Sunitinib—Skin disorder—Capecitabine—stomach cancer	2.48e-05	0.00031	CcSEcCtD
Sunitinib—Urinary tract disorder—Epirubicin—stomach cancer	2.47e-05	0.00031	CcSEcCtD
Sunitinib—Oedema peripheral—Epirubicin—stomach cancer	2.46e-05	0.000309	CcSEcCtD
Sunitinib—Connective tissue disorder—Epirubicin—stomach cancer	2.46e-05	0.000308	CcSEcCtD
Sunitinib—Urethral disorder—Epirubicin—stomach cancer	2.45e-05	0.000307	CcSEcCtD
Sunitinib—Hepatobiliary disease—Doxorubicin—stomach cancer	2.44e-05	0.000306	CcSEcCtD
Sunitinib—Epistaxis—Doxorubicin—stomach cancer	2.43e-05	0.000305	CcSEcCtD
Sunitinib—Anorexia—Capecitabine—stomach cancer	2.43e-05	0.000305	CcSEcCtD
Sunitinib—Angiopathy—Methotrexate—stomach cancer	2.42e-05	0.000304	CcSEcCtD
Sunitinib—Vomiting—Irinotecan—stomach cancer	2.42e-05	0.000304	CcSEcCtD
Sunitinib—Immune system disorder—Methotrexate—stomach cancer	2.41e-05	0.000303	CcSEcCtD
Sunitinib—Dizziness—Fluorouracil—stomach cancer	2.41e-05	0.000302	CcSEcCtD
Sunitinib—Mediastinal disorder—Methotrexate—stomach cancer	2.41e-05	0.000302	CcSEcCtD
Sunitinib—Rash—Irinotecan—stomach cancer	2.4e-05	0.000301	CcSEcCtD
Sunitinib—Dermatitis—Irinotecan—stomach cancer	2.4e-05	0.000301	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Docetaxel—stomach cancer	2.4e-05	0.000301	CcSEcCtD
Sunitinib—Chills—Methotrexate—stomach cancer	2.4e-05	0.000301	CcSEcCtD
Sunitinib—Headache—Irinotecan—stomach cancer	2.39e-05	0.000299	CcSEcCtD
Sunitinib—Insomnia—Docetaxel—stomach cancer	2.38e-05	0.000299	CcSEcCtD
Sunitinib—Paraesthesia—Docetaxel—stomach cancer	2.36e-05	0.000296	CcSEcCtD
Sunitinib—Erythema multiforme—Epirubicin—stomach cancer	2.36e-05	0.000296	CcSEcCtD
Sunitinib—Alopecia—Methotrexate—stomach cancer	2.36e-05	0.000296	CcSEcCtD
Sunitinib—Bradycardia—Doxorubicin—stomach cancer	2.35e-05	0.000295	CcSEcCtD
Sunitinib—Dyspnoea—Docetaxel—stomach cancer	2.35e-05	0.000294	CcSEcCtD
Sunitinib—Mental disorder—Methotrexate—stomach cancer	2.34e-05	0.000293	CcSEcCtD
Sunitinib—Eye disorder—Epirubicin—stomach cancer	2.34e-05	0.000293	CcSEcCtD
Sunitinib—Erythema—Methotrexate—stomach cancer	2.32e-05	0.000292	CcSEcCtD
Sunitinib—Malnutrition—Methotrexate—stomach cancer	2.32e-05	0.000292	CcSEcCtD
Sunitinib—Haemoglobin—Doxorubicin—stomach cancer	2.32e-05	0.000291	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Capecitabine—stomach cancer	2.32e-05	0.000291	CcSEcCtD
Sunitinib—Flushing—Epirubicin—stomach cancer	2.32e-05	0.000291	CcSEcCtD
Sunitinib—Cardiac disorder—Epirubicin—stomach cancer	2.32e-05	0.000291	CcSEcCtD
Sunitinib—Vomiting—Fluorouracil—stomach cancer	2.32e-05	0.000291	CcSEcCtD
Sunitinib—Dyspepsia—Docetaxel—stomach cancer	2.32e-05	0.000291	CcSEcCtD
Sunitinib—Haemorrhage—Doxorubicin—stomach cancer	2.31e-05	0.00029	CcSEcCtD
Sunitinib—Hepatitis—Doxorubicin—stomach cancer	2.31e-05	0.00029	CcSEcCtD
Sunitinib—Insomnia—Capecitabine—stomach cancer	2.3e-05	0.000289	CcSEcCtD
Sunitinib—Hypoaesthesia—Doxorubicin—stomach cancer	2.3e-05	0.000289	CcSEcCtD
Sunitinib—Rash—Fluorouracil—stomach cancer	2.3e-05	0.000288	CcSEcCtD
Sunitinib—Dermatitis—Fluorouracil—stomach cancer	2.3e-05	0.000288	CcSEcCtD
Sunitinib—Paraesthesia—Capecitabine—stomach cancer	2.29e-05	0.000287	CcSEcCtD
Sunitinib—Decreased appetite—Docetaxel—stomach cancer	2.29e-05	0.000287	CcSEcCtD
Sunitinib—Headache—Fluorouracil—stomach cancer	2.28e-05	0.000287	CcSEcCtD
Sunitinib—Urinary tract disorder—Doxorubicin—stomach cancer	2.28e-05	0.000286	CcSEcCtD
Sunitinib—Oedema peripheral—Doxorubicin—stomach cancer	2.28e-05	0.000286	CcSEcCtD
Sunitinib—Dysgeusia—Methotrexate—stomach cancer	2.28e-05	0.000286	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Docetaxel—stomach cancer	2.27e-05	0.000285	CcSEcCtD
Sunitinib—Connective tissue disorder—Doxorubicin—stomach cancer	2.27e-05	0.000285	CcSEcCtD
Sunitinib—ABCC4—lymph node—stomach cancer	2.27e-05	0.000344	CbGeAlD
Sunitinib—Dyspnoea—Capecitabine—stomach cancer	2.27e-05	0.000285	CcSEcCtD
Sunitinib—Fatigue—Docetaxel—stomach cancer	2.27e-05	0.000285	CcSEcCtD
Sunitinib—Angiopathy—Epirubicin—stomach cancer	2.27e-05	0.000284	CcSEcCtD
Sunitinib—Urethral disorder—Doxorubicin—stomach cancer	2.27e-05	0.000284	CcSEcCtD
Sunitinib—Nausea—Irinotecan—stomach cancer	2.26e-05	0.000284	CcSEcCtD
Sunitinib—Immune system disorder—Epirubicin—stomach cancer	2.26e-05	0.000283	CcSEcCtD
Sunitinib—Mediastinal disorder—Epirubicin—stomach cancer	2.25e-05	0.000282	CcSEcCtD
Sunitinib—Constipation—Docetaxel—stomach cancer	2.25e-05	0.000282	CcSEcCtD
Sunitinib—Pain—Docetaxel—stomach cancer	2.25e-05	0.000282	CcSEcCtD
Sunitinib—Back pain—Methotrexate—stomach cancer	2.25e-05	0.000282	CcSEcCtD
Sunitinib—Dyspepsia—Capecitabine—stomach cancer	2.24e-05	0.000281	CcSEcCtD
Sunitinib—Chills—Epirubicin—stomach cancer	2.24e-05	0.000281	CcSEcCtD
Sunitinib—Arrhythmia—Epirubicin—stomach cancer	2.23e-05	0.00028	CcSEcCtD
Sunitinib—Decreased appetite—Capecitabine—stomach cancer	2.22e-05	0.000278	CcSEcCtD
Sunitinib—Alopecia—Epirubicin—stomach cancer	2.21e-05	0.000277	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Capecitabine—stomach cancer	2.2e-05	0.000276	CcSEcCtD
Sunitinib—ABCC2—lymph node—stomach cancer	2.2e-05	0.000333	CbGeAlD
Sunitinib—Fatigue—Capecitabine—stomach cancer	2.2e-05	0.000276	CcSEcCtD
Sunitinib—Mental disorder—Epirubicin—stomach cancer	2.19e-05	0.000275	CcSEcCtD
Sunitinib—Erythema multiforme—Doxorubicin—stomach cancer	2.19e-05	0.000274	CcSEcCtD
Sunitinib—Constipation—Capecitabine—stomach cancer	2.18e-05	0.000273	CcSEcCtD
Sunitinib—Pain—Capecitabine—stomach cancer	2.18e-05	0.000273	CcSEcCtD
Sunitinib—Erythema—Epirubicin—stomach cancer	2.18e-05	0.000273	CcSEcCtD
Sunitinib—Malnutrition—Epirubicin—stomach cancer	2.18e-05	0.000273	CcSEcCtD
Sunitinib—Nausea—Fluorouracil—stomach cancer	2.17e-05	0.000272	CcSEcCtD
Sunitinib—Eye disorder—Doxorubicin—stomach cancer	2.16e-05	0.000271	CcSEcCtD
Sunitinib—CYP3A5—endocrine gland—stomach cancer	2.15e-05	0.000327	CbGeAlD
Sunitinib—Gastrointestinal pain—Docetaxel—stomach cancer	2.15e-05	0.00027	CcSEcCtD
Sunitinib—Anaemia—Methotrexate—stomach cancer	2.15e-05	0.000269	CcSEcCtD
Sunitinib—Cardiac disorder—Doxorubicin—stomach cancer	2.15e-05	0.000269	CcSEcCtD
Sunitinib—Flushing—Doxorubicin—stomach cancer	2.15e-05	0.000269	CcSEcCtD
Sunitinib—Flatulence—Epirubicin—stomach cancer	2.14e-05	0.000269	CcSEcCtD
Sunitinib—Dysgeusia—Epirubicin—stomach cancer	2.13e-05	0.000267	CcSEcCtD
Sunitinib—Back pain—Epirubicin—stomach cancer	2.1e-05	0.000264	CcSEcCtD
Sunitinib—Angiopathy—Doxorubicin—stomach cancer	2.1e-05	0.000263	CcSEcCtD
Sunitinib—ABCG2—liver—stomach cancer	2.09e-05	0.000317	CbGeAlD
Sunitinib—Muscle spasms—Epirubicin—stomach cancer	2.09e-05	0.000262	CcSEcCtD
Sunitinib—Immune system disorder—Doxorubicin—stomach cancer	2.09e-05	0.000262	CcSEcCtD
Sunitinib—Gastrointestinal pain—Capecitabine—stomach cancer	2.08e-05	0.000261	CcSEcCtD
Sunitinib—Mediastinal disorder—Doxorubicin—stomach cancer	2.08e-05	0.000261	CcSEcCtD
Sunitinib—Body temperature increased—Docetaxel—stomach cancer	2.08e-05	0.000261	CcSEcCtD
Sunitinib—Abdominal pain—Docetaxel—stomach cancer	2.08e-05	0.000261	CcSEcCtD
Sunitinib—Leukopenia—Methotrexate—stomach cancer	2.08e-05	0.000261	CcSEcCtD
Sunitinib—Chills—Doxorubicin—stomach cancer	2.07e-05	0.00026	CcSEcCtD
Sunitinib—Arrhythmia—Doxorubicin—stomach cancer	2.07e-05	0.000259	CcSEcCtD
Sunitinib—Alopecia—Doxorubicin—stomach cancer	2.04e-05	0.000256	CcSEcCtD
Sunitinib—Cough—Methotrexate—stomach cancer	2.03e-05	0.000254	CcSEcCtD
Sunitinib—Mental disorder—Doxorubicin—stomach cancer	2.03e-05	0.000254	CcSEcCtD
Sunitinib—Body temperature increased—Capecitabine—stomach cancer	2.01e-05	0.000253	CcSEcCtD
Sunitinib—Abdominal pain—Capecitabine—stomach cancer	2.01e-05	0.000253	CcSEcCtD
Sunitinib—Convulsion—Methotrexate—stomach cancer	2.01e-05	0.000253	CcSEcCtD
Sunitinib—Erythema—Doxorubicin—stomach cancer	2.01e-05	0.000252	CcSEcCtD
Sunitinib—Malnutrition—Doxorubicin—stomach cancer	2.01e-05	0.000252	CcSEcCtD
Sunitinib—Anaemia—Epirubicin—stomach cancer	2.01e-05	0.000252	CcSEcCtD
Sunitinib—ABCB1—hematopoietic system—stomach cancer	1.99e-05	0.000302	CbGeAlD
Sunitinib—Flatulence—Doxorubicin—stomach cancer	1.98e-05	0.000249	CcSEcCtD
Sunitinib—Arthralgia—Methotrexate—stomach cancer	1.98e-05	0.000248	CcSEcCtD
Sunitinib—Myalgia—Methotrexate—stomach cancer	1.98e-05	0.000248	CcSEcCtD
Sunitinib—Chest pain—Methotrexate—stomach cancer	1.98e-05	0.000248	CcSEcCtD
Sunitinib—Dysgeusia—Doxorubicin—stomach cancer	1.97e-05	0.000247	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	1.97e-05	0.000247	CcSEcCtD
Sunitinib—CYP3A4—digestive system—stomach cancer	1.96e-05	0.000297	CbGeAlD
Sunitinib—Leukopenia—Epirubicin—stomach cancer	1.95e-05	0.000244	CcSEcCtD
Sunitinib—Back pain—Doxorubicin—stomach cancer	1.95e-05	0.000244	CcSEcCtD
Sunitinib—CYP3A5—liver—stomach cancer	1.94e-05	0.000294	CbGeAlD
Sunitinib—Hypersensitivity—Docetaxel—stomach cancer	1.94e-05	0.000243	CcSEcCtD
Sunitinib—Muscle spasms—Doxorubicin—stomach cancer	1.93e-05	0.000243	CcSEcCtD
Sunitinib—Cough—Epirubicin—stomach cancer	1.9e-05	0.000238	CcSEcCtD
Sunitinib—Asthenia—Docetaxel—stomach cancer	1.89e-05	0.000237	CcSEcCtD
Sunitinib—Convulsion—Epirubicin—stomach cancer	1.88e-05	0.000236	CcSEcCtD
Sunitinib—Infection—Methotrexate—stomach cancer	1.88e-05	0.000236	CcSEcCtD
Sunitinib—Hypertension—Epirubicin—stomach cancer	1.88e-05	0.000236	CcSEcCtD
Sunitinib—Hypersensitivity—Capecitabine—stomach cancer	1.88e-05	0.000235	CcSEcCtD
Sunitinib—Pruritus—Docetaxel—stomach cancer	1.86e-05	0.000234	CcSEcCtD
Sunitinib—Nervous system disorder—Methotrexate—stomach cancer	1.86e-05	0.000233	CcSEcCtD
Sunitinib—Anaemia—Doxorubicin—stomach cancer	1.86e-05	0.000233	CcSEcCtD
Sunitinib—Thrombocytopenia—Methotrexate—stomach cancer	1.86e-05	0.000233	CcSEcCtD
Sunitinib—Myalgia—Epirubicin—stomach cancer	1.85e-05	0.000232	CcSEcCtD
Sunitinib—Chest pain—Epirubicin—stomach cancer	1.85e-05	0.000232	CcSEcCtD
Sunitinib—Arthralgia—Epirubicin—stomach cancer	1.85e-05	0.000232	CcSEcCtD
Sunitinib—Skin disorder—Methotrexate—stomach cancer	1.84e-05	0.000231	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	1.84e-05	0.000231	CcSEcCtD
Sunitinib—Asthenia—Capecitabine—stomach cancer	1.83e-05	0.000229	CcSEcCtD
Sunitinib—ABCB1—epithelium—stomach cancer	1.82e-05	0.000276	CbGeAlD
Sunitinib—Dry mouth—Epirubicin—stomach cancer	1.81e-05	0.000227	CcSEcCtD
Sunitinib—Anorexia—Methotrexate—stomach cancer	1.81e-05	0.000227	CcSEcCtD
Sunitinib—Pruritus—Capecitabine—stomach cancer	1.8e-05	0.000226	CcSEcCtD
Sunitinib—KCNH2—lymph node—stomach cancer	1.8e-05	0.000273	CbGeAlD
Sunitinib—Leukopenia—Doxorubicin—stomach cancer	1.8e-05	0.000226	CcSEcCtD
Sunitinib—Diarrhoea—Docetaxel—stomach cancer	1.8e-05	0.000226	CcSEcCtD
Sunitinib—Oedema—Epirubicin—stomach cancer	1.78e-05	0.000223	CcSEcCtD
Sunitinib—Infection—Epirubicin—stomach cancer	1.76e-05	0.000221	CcSEcCtD
Sunitinib—Cough—Doxorubicin—stomach cancer	1.76e-05	0.00022	CcSEcCtD
Sunitinib—Shock—Epirubicin—stomach cancer	1.75e-05	0.000219	CcSEcCtD
Sunitinib—Convulsion—Doxorubicin—stomach cancer	1.74e-05	0.000219	CcSEcCtD
Sunitinib—Diarrhoea—Capecitabine—stomach cancer	1.74e-05	0.000219	CcSEcCtD
Sunitinib—Nervous system disorder—Epirubicin—stomach cancer	1.74e-05	0.000218	CcSEcCtD
Sunitinib—Dizziness—Docetaxel—stomach cancer	1.74e-05	0.000218	CcSEcCtD
Sunitinib—Thrombocytopenia—Epirubicin—stomach cancer	1.74e-05	0.000218	CcSEcCtD
Sunitinib—Hypertension—Doxorubicin—stomach cancer	1.74e-05	0.000218	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Methotrexate—stomach cancer	1.73e-05	0.000217	CcSEcCtD
Sunitinib—Skin disorder—Epirubicin—stomach cancer	1.72e-05	0.000216	CcSEcCtD
Sunitinib—Insomnia—Methotrexate—stomach cancer	1.72e-05	0.000215	CcSEcCtD
Sunitinib—Myalgia—Doxorubicin—stomach cancer	1.71e-05	0.000215	CcSEcCtD
Sunitinib—Arthralgia—Doxorubicin—stomach cancer	1.71e-05	0.000215	CcSEcCtD
Sunitinib—Chest pain—Doxorubicin—stomach cancer	1.71e-05	0.000215	CcSEcCtD
Sunitinib—Paraesthesia—Methotrexate—stomach cancer	1.7e-05	0.000214	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	1.7e-05	0.000213	CcSEcCtD
Sunitinib—Anorexia—Epirubicin—stomach cancer	1.69e-05	0.000212	CcSEcCtD
Sunitinib—Dyspnoea—Methotrexate—stomach cancer	1.69e-05	0.000212	CcSEcCtD
Sunitinib—Dizziness—Capecitabine—stomach cancer	1.69e-05	0.000211	CcSEcCtD
Sunitinib—Dry mouth—Doxorubicin—stomach cancer	1.68e-05	0.00021	CcSEcCtD
Sunitinib—Vomiting—Docetaxel—stomach cancer	1.67e-05	0.00021	CcSEcCtD
Sunitinib—Dyspepsia—Methotrexate—stomach cancer	1.67e-05	0.000209	CcSEcCtD
Sunitinib—Rash—Docetaxel—stomach cancer	1.66e-05	0.000208	CcSEcCtD
Sunitinib—Dermatitis—Docetaxel—stomach cancer	1.66e-05	0.000208	CcSEcCtD
Sunitinib—Decreased appetite—Methotrexate—stomach cancer	1.65e-05	0.000207	CcSEcCtD
Sunitinib—Headache—Docetaxel—stomach cancer	1.65e-05	0.000207	CcSEcCtD
Sunitinib—Oedema—Doxorubicin—stomach cancer	1.64e-05	0.000206	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Methotrexate—stomach cancer	1.64e-05	0.000205	CcSEcCtD
Sunitinib—Fatigue—Methotrexate—stomach cancer	1.64e-05	0.000205	CcSEcCtD
Sunitinib—Infection—Doxorubicin—stomach cancer	1.63e-05	0.000205	CcSEcCtD
Sunitinib—Pain—Methotrexate—stomach cancer	1.62e-05	0.000203	CcSEcCtD
Sunitinib—ABCB1—pancreas—stomach cancer	1.62e-05	0.000246	CbGeAlD
Sunitinib—Vomiting—Capecitabine—stomach cancer	1.62e-05	0.000203	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Epirubicin—stomach cancer	1.62e-05	0.000203	CcSEcCtD
Sunitinib—CYP3A4—endocrine gland—stomach cancer	1.62e-05	0.000245	CbGeAlD
Sunitinib—Shock—Doxorubicin—stomach cancer	1.62e-05	0.000203	CcSEcCtD
Sunitinib—Nervous system disorder—Doxorubicin—stomach cancer	1.61e-05	0.000202	CcSEcCtD
Sunitinib—Thrombocytopenia—Doxorubicin—stomach cancer	1.61e-05	0.000202	CcSEcCtD
Sunitinib—Rash—Capecitabine—stomach cancer	1.61e-05	0.000202	CcSEcCtD
Sunitinib—Insomnia—Epirubicin—stomach cancer	1.61e-05	0.000201	CcSEcCtD
Sunitinib—Dermatitis—Capecitabine—stomach cancer	1.61e-05	0.000201	CcSEcCtD
Sunitinib—ABCG2—lymph node—stomach cancer	1.6e-05	0.000243	CbGeAlD
Sunitinib—Headache—Capecitabine—stomach cancer	1.6e-05	0.0002	CcSEcCtD
Sunitinib—Skin disorder—Doxorubicin—stomach cancer	1.6e-05	0.0002	CcSEcCtD
Sunitinib—Paraesthesia—Epirubicin—stomach cancer	1.59e-05	0.0002	CcSEcCtD
Sunitinib—Dyspnoea—Epirubicin—stomach cancer	1.58e-05	0.000199	CcSEcCtD
Sunitinib—Anorexia—Doxorubicin—stomach cancer	1.57e-05	0.000196	CcSEcCtD
Sunitinib—Nausea—Docetaxel—stomach cancer	1.56e-05	0.000196	CcSEcCtD
Sunitinib—Dyspepsia—Epirubicin—stomach cancer	1.56e-05	0.000196	CcSEcCtD
Sunitinib—Gastrointestinal pain—Methotrexate—stomach cancer	1.55e-05	0.000195	CcSEcCtD
Sunitinib—Decreased appetite—Epirubicin—stomach cancer	1.54e-05	0.000194	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Epirubicin—stomach cancer	1.53e-05	0.000192	CcSEcCtD
Sunitinib—Fatigue—Epirubicin—stomach cancer	1.53e-05	0.000192	CcSEcCtD
Sunitinib—Constipation—Epirubicin—stomach cancer	1.52e-05	0.00019	CcSEcCtD
Sunitinib—Pain—Epirubicin—stomach cancer	1.52e-05	0.00019	CcSEcCtD
Sunitinib—Nausea—Capecitabine—stomach cancer	1.51e-05	0.00019	CcSEcCtD
Sunitinib—Abdominal pain—Methotrexate—stomach cancer	1.5e-05	0.000188	CcSEcCtD
Sunitinib—Body temperature increased—Methotrexate—stomach cancer	1.5e-05	0.000188	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Doxorubicin—stomach cancer	1.5e-05	0.000188	CcSEcCtD
Sunitinib—Insomnia—Doxorubicin—stomach cancer	1.49e-05	0.000186	CcSEcCtD
Sunitinib—Paraesthesia—Doxorubicin—stomach cancer	1.47e-05	0.000185	CcSEcCtD
Sunitinib—Dyspnoea—Doxorubicin—stomach cancer	1.46e-05	0.000184	CcSEcCtD
Sunitinib—CYP3A4—liver—stomach cancer	1.46e-05	0.000221	CbGeAlD
Sunitinib—Gastrointestinal pain—Epirubicin—stomach cancer	1.45e-05	0.000182	CcSEcCtD
Sunitinib—Dyspepsia—Doxorubicin—stomach cancer	1.45e-05	0.000181	CcSEcCtD
Sunitinib—Decreased appetite—Doxorubicin—stomach cancer	1.43e-05	0.000179	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Doxorubicin—stomach cancer	1.42e-05	0.000178	CcSEcCtD
Sunitinib—Fatigue—Doxorubicin—stomach cancer	1.42e-05	0.000178	CcSEcCtD
Sunitinib—Pain—Doxorubicin—stomach cancer	1.4e-05	0.000176	CcSEcCtD
Sunitinib—Constipation—Doxorubicin—stomach cancer	1.4e-05	0.000176	CcSEcCtD
Sunitinib—Abdominal pain—Epirubicin—stomach cancer	1.4e-05	0.000176	CcSEcCtD
Sunitinib—Body temperature increased—Epirubicin—stomach cancer	1.4e-05	0.000176	CcSEcCtD
Sunitinib—ABCB1—lymphoid tissue—stomach cancer	1.4e-05	0.000213	CbGeAlD
Sunitinib—Hypersensitivity—Methotrexate—stomach cancer	1.4e-05	0.000175	CcSEcCtD
Sunitinib—ABCB1—digestive system—stomach cancer	1.38e-05	0.00021	CbGeAlD
Sunitinib—Asthenia—Methotrexate—stomach cancer	1.36e-05	0.000171	CcSEcCtD
Sunitinib—Gastrointestinal pain—Doxorubicin—stomach cancer	1.34e-05	0.000168	CcSEcCtD
Sunitinib—Pruritus—Methotrexate—stomach cancer	1.34e-05	0.000168	CcSEcCtD
Sunitinib—Hypersensitivity—Epirubicin—stomach cancer	1.31e-05	0.000164	CcSEcCtD
Sunitinib—Body temperature increased—Doxorubicin—stomach cancer	1.3e-05	0.000163	CcSEcCtD
Sunitinib—Abdominal pain—Doxorubicin—stomach cancer	1.3e-05	0.000163	CcSEcCtD
Sunitinib—Diarrhoea—Methotrexate—stomach cancer	1.3e-05	0.000163	CcSEcCtD
Sunitinib—ABCB1—bone marrow—stomach cancer	1.28e-05	0.000193	CbGeAlD
Sunitinib—Asthenia—Epirubicin—stomach cancer	1.27e-05	0.00016	CcSEcCtD
Sunitinib—Pruritus—Epirubicin—stomach cancer	1.26e-05	0.000158	CcSEcCtD
Sunitinib—Dizziness—Methotrexate—stomach cancer	1.25e-05	0.000157	CcSEcCtD
Sunitinib—Diarrhoea—Epirubicin—stomach cancer	1.21e-05	0.000152	CcSEcCtD
Sunitinib—Hypersensitivity—Doxorubicin—stomach cancer	1.21e-05	0.000152	CcSEcCtD
Sunitinib—Vomiting—Methotrexate—stomach cancer	1.21e-05	0.000151	CcSEcCtD
Sunitinib—Rash—Methotrexate—stomach cancer	1.2e-05	0.00015	CcSEcCtD
Sunitinib—Dermatitis—Methotrexate—stomach cancer	1.19e-05	0.00015	CcSEcCtD
Sunitinib—Headache—Methotrexate—stomach cancer	1.19e-05	0.000149	CcSEcCtD
Sunitinib—Asthenia—Doxorubicin—stomach cancer	1.18e-05	0.000148	CcSEcCtD
Sunitinib—Dizziness—Epirubicin—stomach cancer	1.17e-05	0.000147	CcSEcCtD
Sunitinib—Pruritus—Doxorubicin—stomach cancer	1.16e-05	0.000146	CcSEcCtD
Sunitinib—ABCB1—endocrine gland—stomach cancer	1.14e-05	0.000173	CbGeAlD
Sunitinib—Vomiting—Epirubicin—stomach cancer	1.13e-05	0.000142	CcSEcCtD
Sunitinib—Nausea—Methotrexate—stomach cancer	1.13e-05	0.000141	CcSEcCtD
Sunitinib—Diarrhoea—Doxorubicin—stomach cancer	1.12e-05	0.000141	CcSEcCtD
Sunitinib—Rash—Epirubicin—stomach cancer	1.12e-05	0.00014	CcSEcCtD
Sunitinib—Dermatitis—Epirubicin—stomach cancer	1.12e-05	0.00014	CcSEcCtD
Sunitinib—Headache—Epirubicin—stomach cancer	1.11e-05	0.000139	CcSEcCtD
Sunitinib—Dizziness—Doxorubicin—stomach cancer	1.09e-05	0.000136	CcSEcCtD
Sunitinib—Nausea—Epirubicin—stomach cancer	1.05e-05	0.000132	CcSEcCtD
Sunitinib—Vomiting—Doxorubicin—stomach cancer	1.04e-05	0.000131	CcSEcCtD
Sunitinib—Rash—Doxorubicin—stomach cancer	1.04e-05	0.00013	CcSEcCtD
Sunitinib—Dermatitis—Doxorubicin—stomach cancer	1.03e-05	0.00013	CcSEcCtD
Sunitinib—ABCB1—liver—stomach cancer	1.03e-05	0.000156	CbGeAlD
Sunitinib—Headache—Doxorubicin—stomach cancer	1.03e-05	0.000129	CcSEcCtD
Sunitinib—Nausea—Doxorubicin—stomach cancer	9.76e-06	0.000122	CcSEcCtD
Sunitinib—ABCB1—lymph node—stomach cancer	7.91e-06	0.00012	CbGeAlD
Sunitinib—MAP2K2—Signaling Pathways—JUN—stomach cancer	1.98e-07	1.84e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—HRAS—stomach cancer	1.98e-07	1.84e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—VEGFA—stomach cancer	1.98e-07	1.84e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—VEGFA—stomach cancer	1.98e-07	1.84e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—stomach cancer	1.98e-07	1.84e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—stomach cancer	1.98e-07	1.84e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—KRAS—stomach cancer	1.98e-07	1.83e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTGS2—stomach cancer	1.98e-07	1.83e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—PIK3CA—stomach cancer	1.97e-07	1.82e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—HRAS—stomach cancer	1.97e-07	1.82e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—KRAS—stomach cancer	1.97e-07	1.82e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—STAT3—stomach cancer	1.96e-07	1.82e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—STAT3—stomach cancer	1.96e-07	1.82e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CDKN1B—stomach cancer	1.96e-07	1.82e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—PIK3CA—stomach cancer	1.96e-07	1.82e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—IL6—stomach cancer	1.96e-07	1.82e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL6—stomach cancer	1.96e-07	1.81e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—HRAS—stomach cancer	1.96e-07	1.81e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CDKN1B—stomach cancer	1.95e-07	1.81e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—HRAS—stomach cancer	1.94e-07	1.8e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CCND1—stomach cancer	1.94e-07	1.8e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MYC—stomach cancer	1.94e-07	1.8e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—HRAS—stomach cancer	1.94e-07	1.8e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—HRAS—stomach cancer	1.94e-07	1.79e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—TYMS—stomach cancer	1.94e-07	1.79e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—JUN—stomach cancer	1.94e-07	1.79e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MAPK3—stomach cancer	1.93e-07	1.79e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—PIK3CA—stomach cancer	1.93e-07	1.79e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—stomach cancer	1.93e-07	1.79e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MMP9—stomach cancer	1.93e-07	1.79e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CDKN1A—stomach cancer	1.92e-07	1.78e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GSTM1—stomach cancer	1.91e-07	1.77e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MAPK3—stomach cancer	1.91e-07	1.77e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CXCL8—stomach cancer	1.91e-07	1.77e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL6—stomach cancer	1.9e-07	1.76e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—HRAS—stomach cancer	1.9e-07	1.76e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—HRAS—stomach cancer	1.9e-07	1.76e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MAPK1—stomach cancer	1.9e-07	1.76e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—HRAS—stomach cancer	1.9e-07	1.76e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—EGFR—stomach cancer	1.9e-07	1.76e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—HRAS—stomach cancer	1.89e-07	1.75e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—KRAS—stomach cancer	1.89e-07	1.75e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—PIK3CA—stomach cancer	1.89e-07	1.75e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL6—stomach cancer	1.88e-07	1.75e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MMP9—stomach cancer	1.88e-07	1.75e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—VEGFA—stomach cancer	1.88e-07	1.74e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MYC—stomach cancer	1.88e-07	1.74e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—KRAS—stomach cancer	1.88e-07	1.74e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—VEGFA—stomach cancer	1.88e-07	1.74e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MAPK8—stomach cancer	1.88e-07	1.74e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CDKN1A—stomach cancer	1.88e-07	1.74e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MAPK3—stomach cancer	1.88e-07	1.74e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MAPK3—stomach cancer	1.88e-07	1.74e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—PIK3CA—stomach cancer	1.87e-07	1.73e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL6—stomach cancer	1.87e-07	1.73e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CCND1—stomach cancer	1.87e-07	1.73e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—JUN—stomach cancer	1.87e-07	1.73e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—STAT3—stomach cancer	1.86e-07	1.73e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CDKN1B—stomach cancer	1.86e-07	1.73e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CCND1—stomach cancer	1.86e-07	1.72e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—IL6—stomach cancer	1.86e-07	1.72e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—STAT3—stomach cancer	1.86e-07	1.72e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MYC—stomach cancer	1.86e-07	1.72e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—JUN—stomach cancer	1.86e-07	1.72e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—IL6—stomach cancer	1.85e-07	1.72e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL6—stomach cancer	1.85e-07	1.72e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTT1—stomach cancer	1.85e-07	1.72e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—HRAS—stomach cancer	1.85e-07	1.71e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MAPK1—stomach cancer	1.84e-07	1.71e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—EGFR—stomach cancer	1.84e-07	1.71e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MAPK8—stomach cancer	1.83e-07	1.7e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.83e-07	1.7e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MYC—stomach cancer	1.82e-07	1.69e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MYC—stomach cancer	1.82e-07	1.69e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—HRAS—stomach cancer	1.82e-07	1.69e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—PIK3CA—stomach cancer	1.82e-07	1.68e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PPARG—stomach cancer	1.82e-07	1.68e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MAPK1—stomach cancer	1.82e-07	1.68e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—EGFR—stomach cancer	1.82e-07	1.68e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MMP9—stomach cancer	1.82e-07	1.68e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL6—stomach cancer	1.82e-07	1.68e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL6—stomach cancer	1.82e-07	1.68e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL6—stomach cancer	1.81e-07	1.68e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—HRAS—stomach cancer	1.81e-07	1.68e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL6—stomach cancer	1.81e-07	1.68e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CDKN1A—stomach cancer	1.81e-07	1.68e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—PIK3CA—stomach cancer	1.81e-07	1.68e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MMP9—stomach cancer	1.81e-07	1.67e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ERCC2—stomach cancer	1.8e-07	1.67e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CDKN1A—stomach cancer	1.8e-07	1.67e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—KRAS—stomach cancer	1.79e-07	1.66e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—HRAS—stomach cancer	1.79e-07	1.66e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MAPK1—stomach cancer	1.78e-07	1.65e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MAPK1—stomach cancer	1.78e-07	1.65e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—EGFR—stomach cancer	1.78e-07	1.65e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—EGFR—stomach cancer	1.78e-07	1.65e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.78e-07	1.65e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MAPK3—stomach cancer	1.78e-07	1.65e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CCND1—stomach cancer	1.78e-07	1.65e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MAPK3—stomach cancer	1.78e-07	1.65e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—JUN—stomach cancer	1.77e-07	1.64e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL6—stomach cancer	1.77e-07	1.64e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MAPK8—stomach cancer	1.77e-07	1.64e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MAPK8—stomach cancer	1.76e-07	1.63e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—HRAS—stomach cancer	1.75e-07	1.62e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL6—stomach cancer	1.74e-07	1.62e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—KRAS—stomach cancer	1.74e-07	1.61e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ENO1—stomach cancer	1.74e-07	1.61e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL6—stomach cancer	1.73e-07	1.61e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—PIK3CA—stomach cancer	1.73e-07	1.61e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—VEGFA—stomach cancer	1.73e-07	1.61e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—HRAS—stomach cancer	1.73e-07	1.6e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MYC—stomach cancer	1.73e-07	1.6e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—PIK3CA—stomach cancer	1.73e-07	1.6e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MYC—stomach cancer	1.73e-07	1.6e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MMP9—stomach cancer	1.73e-07	1.6e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CDKN1A—stomach cancer	1.72e-07	1.59e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—KRAS—stomach cancer	1.72e-07	1.59e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—STAT3—stomach cancer	1.72e-07	1.59e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—IL6—stomach cancer	1.71e-07	1.59e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MAPK1—stomach cancer	1.69e-07	1.57e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—EGFR—stomach cancer	1.69e-07	1.57e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MTHFR—stomach cancer	1.69e-07	1.57e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—VEGFA—stomach cancer	1.69e-07	1.57e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MAPK1—stomach cancer	1.69e-07	1.57e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—EGFR—stomach cancer	1.69e-07	1.57e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—KRAS—stomach cancer	1.69e-07	1.56e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—KRAS—stomach cancer	1.69e-07	1.56e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—HRAS—stomach cancer	1.68e-07	1.56e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MAPK8—stomach cancer	1.68e-07	1.56e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—stomach cancer	1.68e-07	1.55e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—STAT3—stomach cancer	1.67e-07	1.55e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—HRAS—stomach cancer	1.67e-07	1.55e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—IL6—stomach cancer	1.67e-07	1.55e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL6—stomach cancer	1.66e-07	1.54e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—PIK3CA—stomach cancer	1.65e-07	1.52e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MAPK3—stomach cancer	1.64e-07	1.52e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ALB—stomach cancer	1.63e-07	1.51e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—VEGFA—stomach cancer	1.63e-07	1.51e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—VEGFA—stomach cancer	1.62e-07	1.5e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—STAT3—stomach cancer	1.61e-07	1.5e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—IL6—stomach cancer	1.61e-07	1.49e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—STAT3—stomach cancer	1.61e-07	1.49e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—HRAS—stomach cancer	1.6e-07	1.49e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—IL6—stomach cancer	1.6e-07	1.48e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—KRAS—stomach cancer	1.6e-07	1.48e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MAPK3—stomach cancer	1.6e-07	1.48e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—HRAS—stomach cancer	1.6e-07	1.48e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—PIK3CA—stomach cancer	1.6e-07	1.48e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—KRAS—stomach cancer	1.6e-07	1.48e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MYC—stomach cancer	1.59e-07	1.48e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—stomach cancer	1.59e-07	1.47e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—PIK3CA—stomach cancer	1.58e-07	1.46e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—NOS3—stomach cancer	1.56e-07	1.45e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CAV1—stomach cancer	1.56e-07	1.45e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MAPK1—stomach cancer	1.56e-07	1.45e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EGFR—stomach cancer	1.56e-07	1.45e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOA1—stomach cancer	1.56e-07	1.44e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MYC—stomach cancer	1.56e-07	1.44e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—VEGFA—stomach cancer	1.55e-07	1.44e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—PIK3CA—stomach cancer	1.55e-07	1.44e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—PIK3CA—stomach cancer	1.55e-07	1.44e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—stomach cancer	1.54e-07	1.43e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MAPK3—stomach cancer	1.54e-07	1.43e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CD44—stomach cancer	1.54e-07	1.43e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL6—stomach cancer	1.54e-07	1.42e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—STAT3—stomach cancer	1.53e-07	1.42e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MAPK3—stomach cancer	1.53e-07	1.42e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6—stomach cancer	1.53e-07	1.42e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—stomach cancer	1.53e-07	1.41e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MAPK1—stomach cancer	1.52e-07	1.41e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EGFR—stomach cancer	1.52e-07	1.41e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—HRAS—stomach cancer	1.52e-07	1.41e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MYC—stomach cancer	1.5e-07	1.39e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—stomach cancer	1.5e-07	1.39e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—stomach cancer	1.5e-07	1.39e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MYC—stomach cancer	1.49e-07	1.38e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—HRAS—stomach cancer	1.48e-07	1.37e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—KRAS—stomach cancer	1.47e-07	1.37e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PIK3CA—stomach cancer	1.47e-07	1.36e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MAPK1—stomach cancer	1.47e-07	1.36e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EGFR—stomach cancer	1.47e-07	1.36e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PIK3CA—stomach cancer	1.47e-07	1.36e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MAPK3—stomach cancer	1.47e-07	1.36e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MAPK1—stomach cancer	1.46e-07	1.35e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EGFR—stomach cancer	1.46e-07	1.35e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—HRAS—stomach cancer	1.46e-07	1.35e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6—stomach cancer	1.46e-07	1.35e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—KRAS—stomach cancer	1.44e-07	1.33e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—HRAS—stomach cancer	1.43e-07	1.33e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—HRAS—stomach cancer	1.43e-07	1.33e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTGS2—stomach cancer	1.43e-07	1.33e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MYC—stomach cancer	1.43e-07	1.32e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—stomach cancer	1.42e-07	1.32e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—stomach cancer	1.42e-07	1.31e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6—stomach cancer	1.41e-07	1.31e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6—stomach cancer	1.4e-07	1.29e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MAPK1—stomach cancer	1.39e-07	1.29e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EGFR—stomach cancer	1.39e-07	1.29e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—KRAS—stomach cancer	1.39e-07	1.28e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—KRAS—stomach cancer	1.38e-07	1.28e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPARG—stomach cancer	1.37e-07	1.27e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6—stomach cancer	1.37e-07	1.27e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6—stomach cancer	1.37e-07	1.27e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—HRAS—stomach cancer	1.36e-07	1.26e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—HRAS—stomach cancer	1.36e-07	1.26e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PIK3CA—stomach cancer	1.35e-07	1.25e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PIK3CA—stomach cancer	1.32e-07	1.22e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—KRAS—stomach cancer	1.32e-07	1.22e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—stomach cancer	1.31e-07	1.21e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.31e-07	1.21e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6—stomach cancer	1.3e-07	1.21e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6—stomach cancer	1.3e-07	1.2e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTP1—stomach cancer	1.28e-07	1.19e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—stomach cancer	1.28e-07	1.18e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PIK3CA—stomach cancer	1.27e-07	1.18e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PIK3CA—stomach cancer	1.27e-07	1.17e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HMOX1—stomach cancer	1.27e-07	1.17e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—HRAS—stomach cancer	1.25e-07	1.16e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ALB—stomach cancer	1.23e-07	1.14e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—stomach cancer	1.23e-07	1.14e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PIK3CA—stomach cancer	1.23e-07	1.14e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—stomach cancer	1.23e-07	1.14e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—HRAS—stomach cancer	1.22e-07	1.13e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PIK3CA—stomach cancer	1.22e-07	1.13e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PIK3CA—stomach cancer	1.21e-07	1.12e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6—stomach cancer	1.2e-07	1.11e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TYMS—stomach cancer	1.19e-07	1.11e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—NOS3—stomach cancer	1.18e-07	1.09e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTM1—stomach cancer	1.18e-07	1.09e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—HRAS—stomach cancer	1.18e-07	1.09e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—HRAS—stomach cancer	1.17e-07	1.09e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—stomach cancer	1.17e-07	1.08e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6—stomach cancer	1.17e-07	1.08e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6—stomach cancer	1.13e-07	1.04e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6—stomach cancer	1.12e-07	1.04e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—HRAS—stomach cancer	1.12e-07	1.04e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ERCC2—stomach cancer	1.11e-07	1.03e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS2—stomach cancer	1.08e-07	1e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6—stomach cancer	1.07e-07	9.93e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MTHFR—stomach cancer	1.04e-07	9.66e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CAV1—stomach cancer	9.61e-08	8.91e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOA1—stomach cancer	9.59e-08	8.89e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CA—stomach cancer	8.8e-08	8.15e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARG—stomach cancer	8.45e-08	7.83e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ALB—stomach cancer	7.6e-08	7.04e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NOS3—stomach cancer	7.27e-08	6.74e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS2—stomach cancer	6.65e-08	6.16e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CA—stomach cancer	6.64e-08	6.15e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CA—stomach cancer	4.09e-08	3.79e-07	CbGpPWpGaD
